Search research articles
Contact Us
Filters
Showing results (161-170 of 186) with videos related to
Page
of 19
Sort By:
Circulation
|
January 26, 2011
Conditional transgenic expression of fibroblast growth factor 9 in the adult mouse heart reduces heart failure mortality after myocardial infarction
Mortimer Korf-Klingebiel, Tibor Kempf, Klaus-Dieter Schlüter, et al.
Cell Stem Cell
|
August 6, 2011
Erythropoietin preserves the endothelial differentiation capacity of cardiac progenitor cells and reduces heart failure during anticancer therapies
Melanie Hoch, Philipp Fischer, Britta Stapel, et al.
Journal of Molecular and Cellular Cardiology
|
August 2, 2008
Ex vivo expanded hematopoietic progenitor cells improve cardiac function after myocardial infarction: role of beta-catenin transduction and cell dose
Christian Templin, Daniel Kotlarz, Jörg Faulhaber, et al.
European Heart Journal
|
October 23, 2010
Signal transducer and activator of transcription 3-mediated regulation of miR-199a-5p links cardiomyocyte and endothelial cell function in the heart: a key role for ubiquitin-conjugating enzymes
Arash Haghikia, Ewa Missol-Kolka, Dimitrios Tsikas, et al.
Journal of the American College of Cardiology
|
December 25, 2007
Highlights of the 2007 scientific sessions of the European Society of Cardiology Vienna, Austria, September 1-5, 2007
Steen D Kristensen, Helmut Baumgartner, Helmut Drexler, et al.
Journal of the American College of Cardiology
|
January 29, 2011
Nebivolol exerts beneficial effects on endothelial function, early endothelial progenitor cells, myocardial neovascularization, and left ventricular dysfunction early after myocardial infarction beyond conventional β1-blockade
Sajoscha A Sorrentino, Carola Doerries, Costantina Manes, et al.
Hypertension (Dallas, Tex. : 1979)
|
May 12, 2010
Impaired endothelial repair capacity of early endothelial progenitor cells in prehypertension: relation to endothelial dysfunction
Giovanna Giannotti, Carola Doerries, Pavani S Mocharla, et al.
American Heart Journal
|
September 26, 2006
A double-blind, randomized, placebo-controlled multicenter clinical trial to evaluate the effects of the angiotensin II receptor blocker candesartan cilexetil on intimal hyperplasia after coronary stent implantation
Peter W Radke, Hans R Figulla, Helmut Drexler, et al.
European Journal of Heart Failure
|
November 14, 2008
Successful treatment of heart failure with devices requires collaboration
Karl Swedberg, John Cleland, Martin R Cowie, et al.
Circulation Research
|
June 12, 2004
Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury
Denise Hilfiker-Kleiner, Andres Hilfiker, Martin Fuchs, et al.
Page
of 19
Search research articles
Search
Showing results (161-170 of 186) with videos related to
Sort By:
Page
of 19
Circulation
|
January 26, 2011
Conditional transgenic expression of fibroblast growth factor 9 in the adult mouse heart reduces heart failure mortality after myocardial infarction
Mortimer Korf-Klingebiel, Tibor Kempf, Klaus-Dieter Schlüter, et al.
Cell Stem Cell
|
August 6, 2011
Erythropoietin preserves the endothelial differentiation capacity of cardiac progenitor cells and reduces heart failure during anticancer therapies
Melanie Hoch, Philipp Fischer, Britta Stapel, et al.
Journal of Molecular and Cellular Cardiology
|
August 2, 2008
Ex vivo expanded hematopoietic progenitor cells improve cardiac function after myocardial infarction: role of beta-catenin transduction and cell dose
Christian Templin, Daniel Kotlarz, Jörg Faulhaber, et al.
European Heart Journal
|
October 23, 2010
Signal transducer and activator of transcription 3-mediated regulation of miR-199a-5p links cardiomyocyte and endothelial cell function in the heart: a key role for ubiquitin-conjugating enzymes
Arash Haghikia, Ewa Missol-Kolka, Dimitrios Tsikas, et al.
Journal of the American College of Cardiology
|
December 25, 2007
Highlights of the 2007 scientific sessions of the European Society of Cardiology Vienna, Austria, September 1-5, 2007
Steen D Kristensen, Helmut Baumgartner, Helmut Drexler, et al.
Journal of the American College of Cardiology
|
January 29, 2011
Nebivolol exerts beneficial effects on endothelial function, early endothelial progenitor cells, myocardial neovascularization, and left ventricular dysfunction early after myocardial infarction beyond conventional β1-blockade
Sajoscha A Sorrentino, Carola Doerries, Costantina Manes, et al.
Hypertension (Dallas, Tex. : 1979)
|
May 12, 2010
Impaired endothelial repair capacity of early endothelial progenitor cells in prehypertension: relation to endothelial dysfunction
Giovanna Giannotti, Carola Doerries, Pavani S Mocharla, et al.
American Heart Journal
|
September 26, 2006
A double-blind, randomized, placebo-controlled multicenter clinical trial to evaluate the effects of the angiotensin II receptor blocker candesartan cilexetil on intimal hyperplasia after coronary stent implantation
Peter W Radke, Hans R Figulla, Helmut Drexler, et al.
European Journal of Heart Failure
|
November 14, 2008
Successful treatment of heart failure with devices requires collaboration
Karl Swedberg, John Cleland, Martin R Cowie, et al.
Circulation Research
|
June 12, 2004
Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury
Denise Hilfiker-Kleiner, Andres Hilfiker, Martin Fuchs, et al.
Page
of 19